1h Free Analyst Time
The infusion systems market is forecasted to grow by USD 1.75 billion during 2024-2029, accelerating at a CAGR of 3.9% during the forecast period. The report on the infusion systems market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing incidence of diseases, increase in number of patients admitted to icus, and high demand of infusion systems in military medical units.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The infusion systems market is segmented as below:
By End-user
- Hospitals
- ASCs
- Diagnostics centers
- Others
By Product Type
- Large volume pumps
- Syringe pumps
- Insulin pumps
- Electronic ambulatory pumps
- Others
By Technology
- Traditional
- Speciality
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the infusion systems market covers the following areas:
- Infusion Systems Market sizing
- Infusion Systems Market forecast
- Infusion Systems Market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by End-user
9 Market Segmentation by Product Type
10 Market Segmentation by Technology
11 Customer Landscape
12 Geographic Landscape
13 Drivers, Challenges, and Opportunity/Restraints
14 Competitive Landscape
15 Competitive Analysis
16 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global infusion systems market: Avanos Medical Inc., B.Braun SE, Baxter International Inc., Becton Dickinson and Co., Epic Medical, Fresenius Kabi AG, ICU Medical Inc., Insulet Corp., JMS North America Corp., Medtronic Plc, Micrel Medical Devices SA, Moog Inc., Nipro Corp., Shenzhen MedRena Biotech Co. Ltd., Smiths Group Plc, SOOIL Development Co. Ltd., Tandem Diabetes Care Inc., Teleflex Inc., Terumo Corp., and Zyno Medical.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is high growth potential in emerging countries."
According to the report, one of the major drivers for this market is the increasing incidence of diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Avanos Medical Inc.
- B.Braun SE
- Baxter International Inc.
- Becton Dickinson and Co.
- Epic Medical
- Fresenius Kabi AG
- ICU Medical Inc.
- Insulet Corp.
- JMS North America Corp.
- Medtronic Plc
- Micrel Medical Devices SA
- Moog Inc.
- Nipro Corp.
- Shenzhen MedRena Biotech Co. Ltd.
- Smiths Group Plc
- SOOIL Development Co. Ltd.
- Tandem Diabetes Care Inc.
- Teleflex Inc.
- Terumo Corp.
- Zyno Medical
